Evidence of the Importance of Nox4 in Production of Hypertension in Dahl Salt-Sensitive Rats

Hypertension

Volumn 67, Issue 2, 2016, Pages 440-450

  Cowley, Allen W ^a   Yang, Chun ^a   Zheleznova, Nadezhda N ^a   Staruschenko, Alexander ^a   Kurth, Theresa ^a   Rein, Lisa ^a   Kumar, Vikash ^a   Sadovnikov, Katherine ^a   Dayton, Alex ^a   Hoffman, Matthew ^a   Ryan, Robert P ^a   Skelton, Meredith M ^a   Salehpour, Fahimeh ^b   Ranji, Mahsa ^b   Geurts, Aron ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b University of Wisconsin Milwaukee   (United States)

Author keywords

Dahl salt sensitive rat; hypertension; Nox4; oxidative stress; renal injury

Indexed keywords

COLLAGEN; FLAVINE ADENINE NUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SODIUM CHLORIDE; NOX4 PROTEIN, RAT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RNA;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DAHL SALT SENSITIVE RAT; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; HYPERTENSION; KIDNEY INJURY; MALE; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RENAL CORTICAL TISSUE; RESPIRATORY CHAIN; ANIMAL; BIOSYNTHESIS; BLOOD PRESSURE; DAHL RAT; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BLOOD PRESSURE; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HYPERTENSION; MALE; NADPH OXIDASE; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; RATS; RATS, INBRED DAHL; RNA;

EID: 84954403695     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.115.06280     Document Type: Article

References (66)

1. Cowley AW, Jr. Renal medullary oxidative stress, pressure-natriuresis, and hypertension. Hypertension. 2008;52:777-786. doi: 10.1161/HYPERTENSIONAHA.107.092858.
2. Cowley AW, Jr, Abe M, Mori T, O'Connor PM, Ohsaki Y, Zheleznova NN. Reactive oxygen species as important determinants of medullary flow, sodium excretion, and hypertension. Am J Physiol Renal Physiol. 2015;308:F179-F197. doi: 10.1152/ajprenal.00455.2014.
3. Manning RD, Jr, Tian N, Meng S. Oxidative stress and antioxidant treatment in hypertension and the associated renal damage. Am J Nephrol. 2005;25:311-317. doi: 10.1159/000086411.
4. Palygin O, Levchenko V, Ilatovskaya DV, Pavlov TS, Ryan RP, Cowley AW, Jr, Staruschenko A. Real-time electrochemical detection of ATP and H202 release in freshly isolated kidneys. Am J Physiol Renal Physiol. 2013;305:F134-F141. doi: 10.1152/ajprenal.00129.2013.
5. Taylor NE, Cowley AW, Jr. Effect of renal medullary H2O2 on saltinduced hypertension and renal injury. Am J Physiol Regul Integr Comp Physiol. 2005;289:R1573-R1579. doi: 10.1152/ajpregu.00525.2005.
6. Taylor NE, Maier KG, Roman RJ, Cowley AW, Jr. NO synthase uncoupling in the kidney of Dahl S rats: role of dihydrobiopterin. Hypertension. 2006;48:1066-1071. doi: 10.1161/01.HYP.0000248751.11383.7c.
7. Taylor NE, Glocka P, Liang M, Cowley AW, Jr. NADPH oxidase in the renal medulla causes oxidative stress and contributes to salt-sensitive hypertension in Dahl S rats. Hypertension. 2006;47:692-698. doi: 10.1161/01.HYP.0000203161.02046.8d.
8. Cifuentes-Pagano E, Csanyi G, Pagano PJ. NADPH oxidase inhibitors: a decade of discovery from Nox2ds to HTS. Cell Mol Life Sci. 2012;69:2315-2325. doi: 10.1007/s00018-012-1009-2.
9. Lassègue B, San Martín A, Griendling KK. Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ Res. 2012;110:1364-1390. doi: 10.1161/CIRCRESAHA.111.243972.
10. Sirker A, Zhang M, Shah AM. NADPH oxidases in cardiovascular disease: insights from in vivo models and clinical studies. Basic Res Cardiol. 2011;106:735-747. doi: 10.1007/s00395-011-0190-z.
11. Takac I, Schröder K, Brandes RP. The Nox family of NADPH oxidases: friend or foe of the vascular system Curr Hypertens Rep. 2012;14:70-78. doi: 10.1007/s11906-011-0238-3.
12. Zou AP, Li N, Cowley AW, Jr. Production and actions of superoxide in the renal medulla. Hypertension. 2001;37(2 pt 2):547-553.
13. Makino A, Skelton MM, Zou AP, Roman RJ, Cowley AW, Jr. Increased renal medullary oxidative stress produces hypertension. Hypertension. 2002;39(2 pt 2):667-672.
14. Paravicini TM, Touyz RM. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care. 2008;31(suppl 2):S170-S180. doi: 10.2337/dc08-s247.
15. Anilkumar N, San Jose G, Sawyer I, Santos CX, Sand C, Brewer AC, Warren D, Shah AM. A 28-kDa splice variant of NADPH oxidase-4 is nuclear-localized and involved in redox signaling in vascular cells. Arterioscler Thromb Vasc Biol. 2013;33:e104-e112. doi: 10.1161/ATVBAHA.112.300956.
16. Brandes RP, Schröder K. Composition and functions of vascular nicotinamide adenine dinucleotide phosphate oxidases. Trends Cardiovasc Med. 2008;18:15-19. doi: 10.1016/j.tcm.2007.11.001.
17. Feng D, Yang C, Geurts AM, Kurth T, Liang M, Lazar J, Mattson DL, O'Connor PM, Cowley AW, Jr. Increased expression of NAD(P)H oxidase subunit p67(phox) in the renal medulla contributes to excess oxidative stress and salt-sensitive hypertension. Cell Metab. 2012;15:201-208. doi: 10.1016/j.cmet.2012.01.003.
18. Gill PS, Wilcox CS. NADPH oxidases in the kidney. Antioxid Redox Signal. 2006;8:1597-1607. doi: 10.1089/ars.2006.8.1597.
19. Massey KJ, Hong NJ, Garvin JL. Angiotensin II stimulates superoxide production in the thick ascending limb by activating NOX4. Am J Physiol Cell Physiol. 2012;303:C781-C789. doi: 10.1152/ajpcell.00457.2011.
20. Chen YF, Cowley AW, Jr, Zou AP. Increased H(2)O(2) counteracts the vasodilator and natriuretic effects of superoxide dismutation by tempol in renal medulla. Am J Physiol Regul Integr Comp Physiol. 2003;285:R827-R833. doi: 10.1152/ajpregu.00636.2002.
21. Makino A, Skelton MM, Zou AP, Cowley AW, Jr. Increased renal medullary H2O2 leads to hypertension. Hypertension. 2003;42:25-30. doi: 10.1161/01.HYP.0000074903.96928.91.
22. Hong NJ, Garvin JL. NADPH oxidase 4 mediates flow-induced superoxide production in thick ascending limbs. Am J Physiol Renal Physiol. 2012;303:F1151-F1156. doi: 10.1152/ajprenal.00181.2012.
23. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev. 2007;87:245-313. doi: 10.1152/physrev.00044.2005.
24. Cowley AW Jr, Roman RJ. The role of the kidney in hypertension. JAMA. 1996;275:1581-1589.
25. Geurts AM, Cost GJ, Freyvert Y, et al. Knockout rats via embryo microinjection of zinc-finger nucleases. Science. 2009;325:433. doi: 10.1126/science.1172447.
26. Geurts AM, Cost GJ, Rémy S, Cui X, Tesson L, Usal C, Ménoret S, Jacob HJ, Anegon I, Buelow R. Generation of gene-specific mutated rats using zinc-finger nucleases. Methods Mol Biol. 2010;597:211-225. doi: 10.1007/978-1-60327-389-3-15.
27. Rezende F, Loewe O, Helfinger V, Prior KK, Walter M, Zukunft S, Fleming I, Weissmann N, Brandes RP, Fleming I, Weissmann N, Brande RP, Schroder K. Unchanged NADPH oxidase activity in Nox1-Nox2-Nox4 triple knockout mice-What do NADPH-stimulated chemiluminescence assays really detect Antioxid Redox Signal. 2015. doi: 10.1089/ars.2015.6314. [Epub ahead of print].
28. Salehpour F, Ghanian Z, Yang C, Zheleznova N, Kurth T, Dash RK, Cowley AW, Jr, Ranji M. Effects of p67phox on the mitochondrial oxidative state in the kidney of Dahl salt-sensitive rats: optical fluorescence 3D cryoimaging. Am J Physiol. 2015;309:F377-F382.
29. Moreno C, Hoffman M, Stodola TJ, Didier DN, Lazar J, Geurts AM, North PE, Jacob HJ, Greene AS. Creation and characterization of a renin knockout rat. Hypertension. 2011;57:614-619. doi: 10.1161/HYPERTENSIONAHA.110.163840.
30. Mattson DL, Lund H, Guo C, Rudemiller N, Geurts AM, Jacob H. Genetic mutation of recombination activating gene 1 in Dahl salt-sensitive rats attenuates hypertension and renal damage. Am J Physiol Regul Integr Comp Physiol. 2013;304:R407-R414. doi: 10.1152/ajpregu.00304.2012.
31. Anilkumar N, Weber R, Zhang M, Brewer A, Shah AM. Nox4 and nox2 NADPH oxidases mediate distinct cellular redox signaling responses to agonist stimulation. Arterioscler Thromb Vasc Biol. 2008;28:1347-1354. doi: 10.1161/ATVBAHA.108.164277.
32. De Miguel C, Guo C, Lund H, Feng D, Mattson DL. Infiltrating T lymphocytes in the kidney increase oxidative stress and participate in the development of hypertension and renal disease. Am J Physiol Renal Physiol. 2011;300:F734-F742. doi: 10.1152/ajprenal.00454.2010.
33. Mori T, Cowley AW, Jr. Role of pressure in angiotensin II-induced renal injury: chronic servo-control of renal perfusion pressure in rats. Hypertension. 2004;43:752-759. doi: 10.1161/01. HYP.0000120971.49659.6a.
34. Mori T, Polichnowski A, Glocka P, Kaldunski M, Ohsaki Y, Liang M, Cowley AW, Jr. High perfusion pressure accelerates renal injury in saltsensitive hypertension. J Am Soc Nephrol. 2008;19:1472-1482. doi: 10.1681/ASN.2007121271.
35. Raij L, Azar S, Keane W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int. 1984;26:137-143.
36. Lu L, Li P, Yang C, Kurth T, Misale M, Skelton M, Moreno C, Roman RJ, Greene AS, Jacob HJ, Lazar J, Liang M, Cowley AW, Jr. Dynamic convergence and divergence of renal genomic and biological pathways in protection from Dahl salt-sensitive hypertension. Physiol Genomics. 2010;41:63-70. doi: 10.1152/physiolgenomics.00170.2009.
37. Morrison J, Knoll K, Hessner MJ, Liang M. Effect of high glucose on gene expression in mesangial cells: upregulation of the thiol pathway is an adaptational response. Physiol Genomics. 2004;17:271-282. doi: 10.1152/physiolgenomics.00031.2004.
38. Sepehr R, Staniszewski K, Maleki S, Jacobs ER, Audi S, Ranji M. Optical imaging of tissue mitochondrial redox state in intact rat lungs in two models of pulmonary oxidative stress. J Biomed Opt. 2012;17:046010. doi: 10.1117/1.JBO.17.4.046010.
39. Staniszewski K, Audi SH, Sepehr R, Jacobs ER, Ranji M. Surface fluorescence studies of tissue mitochondrial redox state in isolated perfused rat lungs. Ann Biomed Eng. 2013;41:827-836. doi: 10.1007/s10439-012-0716-z.
40. Asaba K, Tojo A, Onozato ML, Goto A, Quinn MT, Fujita T, Wilcox CS. Effects of NADPH oxidase inhibitor in diabetic nephropathy. Kidney Int. 2005;67:1890-1898. doi: 10.1111/j.1523-1755.2005.00287.x.
41. Gorin Y, Block K, Hernandez J, Bhandari B, Wagner B, Barnes JL, Abboud HE. Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J Biol Chem. 2005;280:39616-39626. doi: 10.1074/jbc.M502412200.
42. Chance B, Baltscheffsky H. Respiratory enzymes in oxidative phosphorylation. VII. Binding of intramitochondrial reduced pyridine nucleotide. J Biol Chem. 1958;233:736-739.
43. Chance B, Schoener B, Oshino R, Itshak F, Nakase Y. Oxidation-reduction ratio studies of mitochondria in freeze-trapped samples. NADH and flavoprotein fluorescence signals. J Biol Chem. 1979;254:4764-4771.
44. Zheleznova NN, Geurts AM, Yang C, Cowley AW, Jr. Contribution of Nox4 to luminal flow induced H2O2 production in medullary thick ascending limbs of Dahl salt-sensitive rats. Hypertension. 2013;62:A83.
45. Tian Z, Liu Y, Usa K, Mladinov D, Fang Y, Ding X, Greene AS, Cowley AW, Jr, Liang M. Novel role of fumarate metabolism in dahl-salt sensitive hypertension. Hypertension. 2009;54:255-260. doi: 10.1161/HYPERTENSIONAHA.109.129528.
46. Zheleznova NN, Yang C, Ryan RP, Halligan BD, Liang M, Greene AS, Cowley AW, Jr. Mitochondrial proteomic analysis reveals deficiencies in oxygen utilization in medullary thick ascending limb of Henle in the Dahl salt-sensitive rat. Physiol Genomics. 2012;44:829-842. doi: 10.1152/physiolgenomics.00060.2012.
47. You YH, Quach T, Saito R, Pham J, Sharma K. Metabolomics reveal a key role for fumarate in mediating the effects of NADPH oxidase 4 in diabetic kidney disease. J Am Soc Nephrol. 2015. doi: 10.1681/ASN.2015030302. [Epub ahead of print].
48. Liu Y, Taylor NE, Lu L, Usa K, Cowley AW, Jr, Ferreri NR, Yeo NC, Liang M. Renal medullary microRNAs in Dahl salt-sensitive rats: miR-29b regulates several collagens and related genes. Hypertension. 2010;55:974-982. doi: 10.1161/HYPERTENSIONAHA.109.144428.
49. Korrapati MC, Howell LA, Howell LH, Shaner BE, Megyesi JK, Siskind LJ, Schnellmann RG. Suramin: a potential therapy for diabetic nephropathy. PLoS One. 2013;8:e73655. doi: 10.1371/journal.pone.0073655.
50. Oelusarz A, Nichols LA, Grunz-Borgmann EA, Chen G, Akintola AD, Catania JM, Burghardt RC, Trzeciakowski JP, Parrish AR. Overexpression of MMP-7 Increases Collagen 1A2 in the Aging Kidney. Physiol Rep. 2013;1:e00090. doi: 10.1002/phy2.90.
51. Chen CC, Geurts AM, Jacob HJ, Fan F, Roman RJ. Heterozygous knockout of transforming growth factor-1 protects Dahl S rats against high salt-induced renal injury. Physiol Genomics. 2013;45:110-118. doi: 10.1152/physiolgenomics.00119.2012.
52. Ryoo IG, Ha H, Kwak MK. Inhibitory role of the KEAP1-NRF2 pathway in TGF1-stimulated renal epithelial transition to fibroblastic cells: a modulatory effect on SMAD signaling. PLoS One. 2014;9:e93265. doi: 10.1371/journal.pone.0093265.
53. Serrander L, Cartier L, Bedard K, Banfi B, Lardy B, Plastre O, Sienkiewicz A, Fórró L, Schlegel W, Krause KH. NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochem J. 2007;406:105-114. doi: 10.1042/BJ20061903.
54. Takac I, Schröder K, Zhang L, Lardy B, Anilkumar N, Lambeth JD, Shah AM, Morel F, Brandes RP. The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4. J Biol Chem. 2011;286:13304-13313. doi: 10.1074/jbc.M110.192138.
55. Chen F, Haigh S, Barman S, Fulton DJ. From form to function: the role of Nox4 in the cardiovascular system. Front Physiol. 2012;3:412. doi: 10.3389/fphys.2012.00412.
56. Goyal P, Weissmann N, Rose F, Grimminger F, Schäfers HJ, Seeger W, Hänze J. Identification of novel Nox4 splice variants with impact on ROS levels in A549 cells. Biochem Biophys Res Commun. 2005;329:32-39. doi: 10.1016/j.bbrc.2005.01.089.
57. Lyle AN, Deshpande NN, Taniyama Y, Seidel-Rogol B, Pounkova L, Du P, Papaharalambus C, Lassègue B, Griendling KK. Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circ Res. 2009;105:249-259. doi: 10.1161/CIRCRESAHA.109.193722.
58. von Löhneysen K, Noack D, Wood MR, Friedman JS, Knaus UG. Structural insights into Nox4 and Nox2: motifs involved in function and cellular localization. Mol Cell Biol. 2010;30:961-975. doi: 10.1128/MCB.01393-09.
59. Ardanaz N, Pagano PJ. Hydrogen peroxide as a paracrine vascular mediator: regulation and signaling leading to dysfunction. Exp Biol Med (Maywood). 2006;231:237-251.
60. Fu Y, Zhang Y, Wang Z, Wang L, Wei X, Zhang B, Wen Z, Fang H, Pang Q, Yi F. Regulation of NADPH oxidase activity is associated with miRNA-25-mediated NOX4 expression in experimental diabetic nephropathy. Am J Nephrol. 2010;32:581-589. doi: 10.1159/000322105.
61. Montezano AC, Burger D, Ceravolo GS, Yusuf H, Montero M, Touyz RM. Novel Nox homologues in the vasculature: focusing on Nox4 and Nox5. Clin Sci (Lond). 2011;120:131-141. doi: 10.1042/CS20100384.
62. Kim SM, Kim YG, Jeong KH, Lee SH, Lee TW, Ihm CG, Moon JY. Angiotensin II-induced mitochondrial Nox4 is a major endogenous source of oxidative stress in kidney tubular cells. PLoS One. 2012;7:e39739. doi: 10.1371/journal.pone.0039739.
63. Yu L, Liu Y, Wu Y, Liu Q, Feng J, Gu X, Xiong Y, Fan Q, Ye J. Smad3/Nox4-mediated mitochondrial dysfunction plays a crucial role in puromycin aminonucleoside-induced podocyte damage. Cell Signal. 2014;26:2979-2991. doi: 10.1016/j.cellsig.2014.08.030.
64. Jha JC, Gray SP, Barit D, Okabe J, El-Osta A, Namikoshi T, Thallas-Bonke V, Wingler K, Szyndralewiez C, Heitz F, Touyz RM, Cooper ME, Schmidt HH, Jandeleit-Dahm KA. Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy. J Am Soc Nephrol. 2014;25:1237-1254. doi: 10.1681/ASN.2013070810.
65. Laleu B, Gaggini F, Orchard M, Fioraso-Cartier L, Cagnon L, Houngninou-Molango S, Gradia A, Duboux G, Merlot C, Heitz F, Szyndralewiez C, Page P. First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis. J Med Chem. 2010;53:7715-7730. doi: 10.1021/jm100773e.
66. Nistala R, Whaley-Connell A, Sowers J.R. Redox control of renal function and hypertension. Antioxid Redox Signal. 2008;10:2047-2089. doi: 10.1089/ars.2008.2034.